PRESS RELEASE TiGenix strengthens European IP protection around lead development program Cx601 Leuven BELGIUM November 2 2017 0700h CET TiGenix NV Euronext Brussels and NASDAQ TIG an advanced biopharmaceutical company focused on exploiting the an...
↧